HOLX - Hologic EPS beats by $0.60 beats on revenue

Hologic (NASDAQ:HOLX): FQ4 Non-GAAP EPS of $1.61 beats by $0.60; GAAP EPS of $1.28 beats by $0.57. Revenue of $1.32B (-2.2% Y/Y) beats by $280M. Press Release Guidance FY22: “We expect strong financial results in fiscal 2022, with solid growth in our core women’s health businesses and a meaningful contribution from COVID-19 testing,” said Karleen Oberton, Hologic’s CFO. FY22: Revenue: $3.75B - $4B (consensus $3.93B); non-GAAP EPS: $3.55 - $3.85 (consensus $3.69): GAAP EPS: $$2.50-$2.80.

For further details see:

Hologic EPS beats by $0.60, beats on revenue